Emergent BioSolutions (EBS) FCF Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly FCF Margin of 23.19% for Q1 2026, down 1653.0% year-over-year from 1.49% in Q1 2025, and down 144.27% quarter-over-quarter from 52.39% in Q4 2025.
Emergent BioSolutions (EBS) FCF Margin (2011 - 2026) Analysis & Trends
Emergent BioSolutions' FCF Margin history runs 16 years deep, the most recent figure standing at 23.19% for Q1 2026.
- In Q1 2026, FCF Margin fell 1653.0% year-over-year to 23.19%; the TTM figure through Mar 2026 stood at 21.81% (up 1038.0% YoY), while the FY2025 annual figure was 22.75%, up 1932.0% from the prior year.
- FCF Margin for Q1 2026 stood at 23.19%, down from 52.39% in the prior quarter.
- The five-year high for FCF Margin was 73.46% in Q2 2025, with the low at 116.74% in Q1 2023.
- The 5-year median for FCF Margin is 6.66% (2025), against an average of 0.51%.
- The sharpest annual moves came in 2023 and 2024: FCF Margin plunged 9394 bps in 2023, then jumped 11052 bps in 2024.
- Emergent BioSolutions' FCF Margin stood at 53.18% in 2022, then slumped by 107 bps to 3.72% in 2023, then sank by 1025 bps to 41.91% in 2024, then jumped by 225 bps to 52.39% in 2025, then slumped by 144 bps to 23.19% in 2026.
- Business Quant data shows EBS's FCF Margin at 23.19% in Q1 2026, 52.39% in Q4 2025, and 1.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | 23.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.05% |
| Mar 31, 2026 | -23.19% |
| Dec 31, 2025 | 52.39% |
| Sep 30, 2025 | 1.04% |
| Jun 30, 2025 | 73.46% |
| Mar 31, 2025 | -6.66% |
| Dec 31, 2024 | -41.91% |
| Sep 30, 2024 | 50.34% |
| Jun 30, 2024 | 70.80% |
| Mar 31, 2024 | -21.94% |
| Dec 31, 2023 | -3.72% |
| Sep 30, 2023 | 28.98% |
| Jun 30, 2023 | -39.72% |
| Mar 31, 2023 | -116.74% |
| Dec 31, 2022 | 53.18% |
| Sep 30, 2022 | -42.48% |
| Jun 30, 2022 | -19.66% |
| Mar 31, 2022 | -22.80% |
| Dec 31, 2021 | 42.04% |
| Sep 30, 2021 | 16.91% |